Skip to main content

HHSC to Remove Oxbryta Products From All Formularies on October 10, 2024

Last updated on

On October 10, 2024, the Texas Vendor Drug Program (VDP) will remove all Oxbryta products from all formularies as a voluntary withdrawal due to safety concerns. This follows an announcement by the U.S. Food and Drug Administration (FDA) on September 26, 2024, about the voluntary withdrawal of Oxbryta.

As a result of this announcement, the following drugs will be removed from all formularies:

National Drug CodeDrug Name
72786010101Oxbryta 500 mg tablet
72786011102Oxbryta 300 mg tablet for susp
72786011103Oxbryta 300 mg tablet for susp
72786010202Oxbryta 300 mg tablet
72786010203Oxbryta 300 mg tablet

Email vdp-formulary@hhsc.state.tx.us with comments or questions.